Distribution of genotypes and alleles of the aldosterone-synthase gene in patients with abdominal obesity

Distribution of genotypes and alleles of the aldosterone-synthase gene in patients with abdominal obesity

We observed 140 patients with abdominal obesity (AO) (IDF, 2005), the residents of St. Petersburg (44.6 ± 0.6 years). Metabolic syndrome (MS) (IDF, 2005) was diagnosed in 49.2% of patients with AO. The most frequent component of MS in patients with AO was arterial hypertension (AH). The distribution...

Full description

Bibliographic Details
Main Authors:	D. L. Brovin, E. A. Bazhenova, R. E. Popov, O. D. Belyaeva, A. V. Berezina, T. L. Karonova, N. A. Korelskaya, T. G. Ivanova, S. N. Pchelina, E. I. Baranova, O. A. Berkovich, E. V. Schlyakhto
Format:	Article
Language:	Russian
Published:	Academician I.P. Pavlov First St. Petersburg State Medical University 2015-06-01
Series:	Учёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова
Subjects:	абдоминальное ожирение артериальная гипертензия ренин-ангиотензин-альдостероновая система полиморфизм альдостерон-синтаза abdominal obesity arterial hypertension renin-angiotensin-aldosterone system polymorphism aldosterone-synthase
Online Access:	https://www.sci-notes.ru/jour/article/view/83

Similar Items

The role of aldosterone in the development of atrial fibrillation: modern understanding of problem
by: N. T. Vatutin, et al.
Published: (2019-03-01)

INFLUENCE OF COMORBIDITIES ON BLOOD ALDOSTERONE LEVEL IN CHRONIC HEART FAILURE WITH PRESERVED SYSTOLIC FUNCTION OF THE LEFT VENTRICLE
by: N. T. Vatutin, et al.
Published: (2017-12-01)

ALDOSTERONE AND OBESITY: WHERE TO LOOK FOR THE KEY TO THERAPY?
by: N. T. Vatutin, et al.
Published: (2016-08-01)

THE USE OF MINERALOCORTICOID RECEPTOR ANTAGONISTS IN THE PRE VENTION OF ATRIAL FIBRILLATION
by: N. T. Vatutin, et al.
Published: (2019-07-01)

Vitamin D role in arterial hypertension development
by: E. N. Dudinskaya, et al.
Published: (2012-06-01)

Effectiveness of an angiotensin II receptor blocker losartan as monoand combined therapy in hypertensive patients with various levels of renin-angiotensin-aldosterone system activity
by: Sh. V. Akhadov, et al.
Published: (2011-02-01)

RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM AND REPLICATIVE CELLULAR SENESCENCE: THEIR INTERACTION DURING THE VASCULAR AGEING
by: V. S. Pykhtina, et al.
Published: (2015-09-01)

Blood aldosterone level in various types of atrial fibrillation
by: N. T. Vatutin, et al.
Published: (2016-02-01)

Патогенез артериальной гипертензии (Лекция)
by: Дмитрий Игоревич Василевский, et al.
Published: (2020-12-01)

Arterial hypertension progression and changing activity of reninangiotensin-aldosterone and sympatho-adrenal systems
by: Sh. V. Akhadov, et al.
Published: (2010-04-01)

Current approach to antihypertensive therapy
by: M. V. Kuznetsova
Published: (2015-12-01)

Comparative effects of renin-angiotensin-aldosterone system modulators on right heart function and prognosis in patients with severe systolic chronic heart failure
by: K. G. Adamyan, et al.
Published: (2012-12-01)

Angiotensin II type 1 receptor antagonists and ACE inhibitors in the regulation of hemodynamics and renin-angiotensin-aldosterone system activity: focus on the organ protection
by: M. L. Maksimov, et al.
Published: (2010-04-01)

Myocardial functional status in patients with arterial hypertension and hyperaldosteronism: orthogonal electrocardiography assessment
by: Kh. F. Samedova, et al.
Published: (2006-04-01)

Показатели вариабельности ритма сердца, активности ренина и содержания альдостерона в плазме крови при ренопаренхиматозной артериальной гипертензии
by: Н. Ю. Боровкова, et al.
Published: (2011-04-01)

MECHANISMS OF COMBINED ACTION OF ACE INHIBITORS AND CALCIUM ANTAGONISTS IN ARTERIAL HYPERTENSION
by: E. I. Astashkin, et al.
Published: (2013-06-01)

Heart and pulmonary artery remodeling association with various levels of natriuretic peptides and renin-angiotensin-aldosterone system activation in patients with pulmonary hypertension of various etiology
by: Yu. A. Andreeva, et al.
Published: (2008-12-01)

RENIN AND ALDOSTERONE PRODUCTION IN CHILDREN WITH HYDRONEPHROSIS WITH RELATION TO THE SEVERITY OF NON-DIFFERENTIATED CONNECTIVE TISSUE DYSPLASIA AND TIME OF URINAL OBSTRUCTION ELIMINATION
by: A.M. Mambetova, et al.
Published: (2011-11-01)

ВЛИЯНИЕ АБДОМИНАЛЬНОГО ОЖИРЕНИЯ НА ФОРМИРОВАНИЕ АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИИ
by: Юлия Александровна Фоминых, et al.
Published: (2022-11-01)

Primary idiopathic hyperaldosteronism in clinical practice
Published: (2012-12-01)

Carotid intima-media thickness and C-reactive protein in patients with abdominal obesity
by: O. D. Belyaeva, et al.
Published: (2009-08-01)

INVERSION OF THE CONCEPT ABOUT BIOLOGICAL ROLE OF RENIN → ANGIOTENSIN-II → ALDOSTERONE SYSTEM AND FUNCTION OF ARTERIAL BLOOD PRESSURE AS A METABOLISM REGULATOR
by: V. N. Titov
Published: (2015-09-01)

Change of the level of adiponectin and metabolic indices in modification of life style of the patients suffering from abdominal obesity
by: A. V. Beresina, et al.
Published: (2015-03-01)

Arterial hypertension in young people and adolescents: diagnostics and treatment
by: O. A. Kislyak, et al.
Published: (2009-04-01)

Apelin and heart remodeling in patients with abdominal obesity
by: O. V. Listopad, et al.
Published: (2015-06-01)

SARTANS AND ANGIOTENSIN CONVERTING ENZYME INHIBITORS: A DUEL BETWEEN TWO LEADERS OF PHARMACOTHERAPY OF CARDIOVASCULAR DISEASES
by: K. A. Gyamdzhyan, et al.
Published: (2015-12-01)

Aldosterone-to-renin ratio (ARR) as a screening tool for primary aldosteronism (PA)
by: Chia-Hung Lin, et al.
Published: (2024-03-01)

Pathogenesis of Primary Aldosteronism: Impact on Clinical Outcome
by: Lucas S. Santana, et al.
Published: (2022-06-01)

Predictive performance of aldosterone-to-renin ratio in the diagnosis of primary aldosteronism in patients with resistant hypertension
by: Fabio Bioletto, et al.
Published: (2023-05-01)

Functional Characteristic and Significance of Aldosterone-Producing Cell Clusters in Primary Aldosteronism and Age-Related Hypertension
by: Fatin Athirah Pauzi, et al.
Published: (2021-03-01)

Pharmacogenetic aspects of eprosartan therapy and polymorphic markers of renin-angiotensin-aldosterone system genes in Uzbek patients with essential arterial hypertension
by: D. R. Kurbanova, et al.
Published: (2009-06-01)

Survey of renin and aldosterone testing practices by Ontario laboratories – Providing insight into best practices
by: Angela C. Rutledge, et al.
Published: (2021-05-01)

Primary Aldosteronism and Pregnancy
by: Tomáš Zelinka, et al.
Published: (2020-02-01)

Diagnosis and management of primary aldosteronism
by: Leticia A. P. Vilela, et al.

Association of insertion deletion polymorphism of the ACE gene with factors of circulating rennin-angiotensin-aldosterone system and endothelial function of skin microvassals in preeclampsia
by: O. V. Radkov, et al.
Published: (2011-08-01)

The Effect of Antihypertensive Medications on Testing for Primary Aldosteronism
by: Piotr Jędrusik, et al.
Published: (2021-05-01)

Quantitative Value of Aldosterone‐Renin Ratio for Detection of Aldosterone‐Producing Adenoma: The Aldosterone‐Renin Ratio for Primary Aldosteronism (AQUARR) Study
by: Giuseppe Maiolino, et al.
Published: (2017-05-01)

Polymorphism of genes of arterial hypertension among children with obesity and arterial hypertension
by: G. S. Maskova, et al.
Published: (2021-02-01)

С(-344)Т polymorphism of aldosterone synthase gene, risk of metabolic syndrome, and atrial fibrillation risk for inhabitants of the Northwest regions of Russia
by: I. Ma, et al.
Published: (2016-06-01)

Aldosterone-Regulating Receptors and Aldosterone-Driver Somatic Mutations
by: Jung Soo Lim, et al.
Published: (2021-03-01)